TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer
Molecular Therapy: Oncology
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001700?dgcid=rss_sd_all
TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001700?dgcid=rss_sd_all
“TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.” Molecular Therapy: Oncology.
@article{article108276,
title = {TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001700?dgcid=rss_sd_all}
}